Showing results (5661-5670 of 11,427) with videos related to

Sort By:
Pageof 1,143
JAMA Network Open|November 23, 2022
Association of Concomitant Gestational Hypertensive Disorders and Gestational Diabetes With Cardiovascular DiseaseJustin B Echouffo Tcheugui, Jun Guan, Longdi Fu, et al.
JAMA Network Open|November 23, 2022
Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal CancerYandong Zhao, Jingjing Wu, Fengyun Pei, et al.
JAMA Network Open|July 6, 2022
Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 PandemicSara C Keller, Tania M Caballero, Pranita D Tamma, et al.
JAMA Network Open|July 6, 2022
Characteristics and Procedures Among Adults Discharged to Hospice After Gastrointestinal Tract Surgery in CaliforniaAnya L Greenberg, Joseph A Lin, Alexis Colley, et al.
JAMA Network Open|July 6, 2022
Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in ChildrenVishal Midya, Elena Colicino, David V Conti, et al.
JAMA Network Open|July 6, 2022
Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the USMark Lee, Eric Whitsel, Christy Avery, et al.
JAMA Network Open|October 8, 2020
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysisJing Wang, Min Zhou, Jing-Yan Xu, et al.
JAMA Network Open|October 8, 2020
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine SourceJesse D Sutton, Vanessa W Stevens, Nai-Chung N Chang, et al.
JAMA Network Open|October 12, 2020
Trends in the Incidence of Central Precocious Puberty and Normal Variant Puberty Among Children in Denmark, 1998 to 2017Elvira V Bräuner, Alexander S Busch, Camilla Eckert-Lind, et al.
JAMA Network Open|October 14, 2020
Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the USTina R Watson, Xin Gao, Kerry L Reynolds, et al.
Pageof 1,143